Chlamydophila Infections

01/23/2001 - "Chlamydia pneumoniae infection in circulating human monocytes is refractory to antibiotic treatment."
01/01/1995 - "We studied the effects of two antibiotic regimens on the course of Chlamydia pneumoniae infection in the lungs of Swiss Webster mice. "
03/01/2005 - "Several small clinical trials have indicated that antibiotic treatment of Chlamydia pneumoniae infection is associated with a better outcome in patients with coronary artery disease (CAD). "
11/12/2008 - "The ongoing debate over the association between Chlamydia pneumoniae infection and coronary artery disease: antibiotic dilemma."
06/01/2005 - "Although Chlamydia pneumoniae infection has been associated with the initiation and progression of atherosclerosis, results of clinical trials investigating antichlamydial antibiotics as adjuncts to standard therapy in patients with coronary artery disease (CAD) have been inconsistent. "

07/14/2005 - "The results of this study do not support the hypothesis that infection with Chlamydia pneumoniae may be a triggering agent or even a causative agent in PBC, but suggest that Chlamydia pneumoniae infection probably contributes to the high level of IgM present in most patients with PBC."
09/01/2004 - "The results of this study do not support the hypothesis that infection with Chlamydia pneumoniae may be a triggering agent for PBC, but suggest that Chlamydia pneumoniae infection probably contributes to the high level of IgM presented in most of the patients with PBC"
11/01/1992 - "Twenty-five subjects (4.9%) showed serological evidence of recent Chlamydia pneumoniae infection (IgM positive and (or) IgG seroconversion); 11 of them also showed serological evidence of recent infection with at least one other chlamydial species. "
01/01/2003 - "For the serological diagnosis of acute Chlamydia pneumoniae infection, the microimmunofluorescence (MIF) test is the most commonly used method and also the "gold standard" for the measurement of immunoglobulin G (IgG) and IgM antibodies. "
03/01/1997 - "Evaluation of Chlamydia immunoglobulin M (IgM), IgG, and IgA rELISAs Medac for diagnosis of Chlamydia pneumoniae infection."

10/01/2005 - "Lack of PBC-specific antimitochondrial antibodies in patients with Chlamydia pneumoniae infection."
02/01/2002 - "Chronic Chlamydia pneumoniae infection is considered as a cardiovascular risk factor and antibodies are commonly analysed by the subjective microimmunofluorescence (MIF) test. "
12/01/2000 - "Chlamydia pneumoniae infection is often diagnosed by analyzing specific antibodies to C. "
11/15/2008 - "Lack of association between serum antibodies of Chlamydia pneumoniae infection and the risk of lung cancer."
05/01/1996 - "[Chlamydia pneumoniae infection associated with autoimmune hemolytic anemia due to warm antibodies]."

02/01/1999 - "IgG levels were also higher during the winter months suggesting seasonal variation of Chlamydia pneumoniae infection. "
12/01/1998 - "The diagnosis of Chlamydia pneumoniae infection was based on the detection of Chlamydia pneumoniae specific IgG antibody in samples from both the acute and convalescent phase, using an indirect microimmunofluorescent technique. "
02/01/1992 - "The high prevalence of persistent IgG, indicating earlier infection, suggests that Chlamydia pneumoniae infection may be endemic in Budapest. "
01/01/2002 - "IgG antibodies indicative of an active Chlamydia pneumoniae infection were detected by microimmunofluorescence in two of nine PCR-positive patients but in none of 41 PCR-negative patients. "
01/01/1998 - "IgG subclass-specific antibodies in Chlamydia pneumoniae infections."

02/20/2019 - "Relative to that of uninfected astrocytes, BACE1 and PSEN1 protein levels were enhanced by nearly twofold at 48-72 h post-Chlamydia pneumoniae infection. "
12/17/2002 - "Chlamydia pneumoniae infection alters the junctional complex proteins of human brain microvascular endothelial cells."
01/04/2007 - "Intranasal administration of chlamydial outer protein N (CopN) induces protection against pulmonary Chlamydia pneumoniae infection in a mouse model."
07/01/2015 - "During Chlamydia pneumoniae infection, the expression and activity of AP-1 family proteins c-Jun, c-Fos, and ATF-2 were regulated in a time- and dose-dependent manner. "
02/20/2019 - "We hypothesized that Chlamydia pneumoniae infection of human astrocytes alters the expression of the amyloid precursor protein (APP)-processing secretases, ADAM10, BACE1, and PSEN1, to promote β-amyloid formation. "

11/01/2006 - "The lack of specific tests for the diagnosis of chronic Chlamydia pneumoniae infection has led to the use of enzyme immunoassay (EIA) instead of the gold standard, that is, microimmunofluorescence (MIF), in the measurement of C. "
07/01/1994 - "Diagnosis of Chlamydia pneumoniae infection in patients with community-acquired pneumonia by polymerase chain reaction enzyme immunoassay."
03/01/2003 - "Measurement of IgG antibodies to Chlamydia trachomatis by commercial enzyme immunoassays and immunofluorescence in sera from pregnant women and patients with infertility, pelvic inflammatory disease, ectopic pregnancy, and laboratory diagnosed Chlamydia psittaci/Chlamydia pneumoniae infection."

10/01/2004 - "Telithromycin treatment of chronic Chlamydia pneumoniae infection in C57BL/6J mice."
06/01/2004 - "Treatment of acute Chlamydia pneumoniae infection with telithromycin in C57BL/6J mice."
06/01/2004 - "The efficacy of telithromycin, a new ketolide antibiotic, was investigated in the treatment of acute Chlamydia pneumoniae infection in a mouse model. "

07/01/2008 - "In interleukin-10 knock out (IL-10 KO) mice, accelerated clearance of pulmonary Chlamydia pneumoniae infection was observed. "
07/01/2008 - "Chlamydia pneumoniae infection in IL-10 knock out mice: accelerated clearance but severe pulmonary inflammatory response."

11/01/2005 - "The efficacy of sparfloxacin (SPFX) for the control of bronchial asthma was evaluated in 26 patients with suspected Chlamydia pneumoniae infection. "
11/01/2005 - "Usefulness of sparfloxacin against Chlamydia pneumoniae infection in patients with bronchial asthma."

01/01/2004 - "Intermittent azithromycin treatment for respiratory symptoms in patients with chronic Chlamydia pneumoniae infection."
01/01/2012 - "This controlled preliminary trial investigated an extended dose of azithromycin in the treatment of Chlamydia pneumoniae infection causing coronary artery disease (CAD). "
01/01/2012 - "Oral azithromycin in extended dosage schedule for chronic, subclinical Chlamydia pneumoniae infection causing coronary artery disease: a probable cure in sight? "
10/08/2002 - "Effect of azithromycin on endothelial function of patients with coronary artery disease and evidence of Chlamydia pneumoniae infection."
03/19/2002 - "Effect of azithromycin treatment on endothelial function in patients with coronary artery disease and evidence of Chlamydia pneumoniae infection."

01/04/2007 - "Intranasal administration of chlamydial outer protein N (CopN) induces protection against pulmonary Chlamydia pneumoniae infection in a mouse model."

01/01/2000 - "The results suggest a need to diagnose chronic Chlamydia pneumoniae infection in COPD patients and, if confirmed, to take an attempt of antimicrobial therapy."
08/01/2006 - "Both hepatitis C virus and Chlamydia pneumoniae infection are related to the progression of carotid atherosclerosis in patients undergoing lipid lowering therapy."
06/01/2005 - "Although Chlamydia pneumoniae infection has been associated with the initiation and progression of atherosclerosis, results of clinical trials investigating antichlamydial antibiotics as adjuncts to standard therapy in patients with coronary artery disease (CAD) have been inconsistent. "
02/04/2023 - "Salmonella typhi infections are linked with gallbladder cancer, and Chlamydia pneumoniae infection is implicated in lung cancer, etc. This knowledge helps identify the adaptation strategies used by bacteria to evade antibiotic/antimicrobial therapy. "
01/01/1998 - "Antimicrobial therapy must take into account the development of reduced susceptibility of penicillin to strains of Streptoccocus pneumoniae and Haemophilus influenzae with beta-lactamase, and high frequency of Mycoplasma pneumoniae and Chlamydia pneumoniae infections. "

12/01/2001 - "Effect of Chlamydia pneumoniae infection on coronary flow reserve and intimal hyperplasia after stent implantation in patients with angina pectoris."
06/30/2001 - "Treatment of Chlamydia pneumoniae infection with roxithromycin and effect on neointima proliferation after coronary stent placement (ISAR-3): a randomised, double-blind, placebo-controlled trial."

03/30/1999 - "Randomized secondary prevention trial of azithromycin in patients with coronary artery disease and serological evidence for Chlamydia pneumoniae infection: The Azithromycin in Coronary Artery Disease: Elimination of Myocardial Infection with Chlamydia (ACADEMIC) study."

11/01/2006 - "Outbreak of Chlamydia pneumoniae infection in a Japanese nursing home, 1999-2000."
10/01/2001 - "[Field epidemiological investigation on an outbreak of Chlamydia pneumoniae infection--first recognized incidence in a nursing home for elderly in Japan]."
04/16/1997 - "To determine the extent and severity of illness and mode of transmission of Chlamydia pneumoniae infection in 3 nursing home outbreaks. "